Pages that link to "Item:Q4506030"
From MaRDI portal
The following pages link to Estimating medical costs with censored data (Q4506030):
Displaying 41 items.
- Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial (Q106180) (← links)
- On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data (Q143546) (← links)
- Accelerated failure time model with quantile information (Q314576) (← links)
- Backward estimation of stochastic processes with failure events as time origins (Q614180) (← links)
- Estimating the mean of a mark variable under right censoring on the basis of a state function (Q901548) (← links)
- Estimation of survival quantiles in two-stage randomization designs (Q1011545) (← links)
- A random effects four-part model, with application to correlated medical costs (Q1023789) (← links)
- Quantile regression methods with varying-coefficient models for censored data (Q1663290) (← links)
- Semiparametric quantile regression with random censoring (Q2304246) (← links)
- Generalized redistribute-to-the-right algorithm: application to the analysis of censored cost data (Q2320839) (← links)
- Modeling right-censored medical cost data in regression and the effects of covariates (Q2324294) (← links)
- Nonparametric identification and estimation of dynamic treatment effects for survival data in a regression discontinuity design (Q2327078) (← links)
- Nonparametric inference for the joint distribution of recurrent marked variables and recurrent survival time (Q2356623) (← links)
- Evaluating costs with unmeasured confounding: a sensitivity analysis for the treatment effect (Q2441849) (← links)
- Estimation of medical costs by copula models with dynamic change of health status (Q2445362) (← links)
- An extension of estimating equations to model longitudinal medical cost trajectory with medicare claims data linked to SEER cancer registry (Q2686085) (← links)
- Model selection and inference for censored lifetime medical expenditures (Q2827182) (← links)
- Utilizing Propensity Scores to Estimate Causal Treatment Effects with Censored Time-Lagged Data (Q3078885) (← links)
- Median Regression with Censored Cost Data (Q3079002) (← links)
- Semiparametric median residual life model and inference (Q3086520) (← links)
- Estimating Mean Cost Using Auxiliary Covariates (Q3100804) (← links)
- Nonparametric Inference for Median Costs with Censored Data (Q4649045) (← links)
- Nonparametric Estimation for Censored Mixture Data With Application to the Cooperative Huntington’s Observational Research Trial (Q4904711) (← links)
- Semiparametric Estimation of Longitudinal Medical Cost Trajectory (Q4962425) (← links)
- Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial (Q4975358) (← links)
- An improved survival estimator for censored medical costs with a kernel approach (Q5075485) (← links)
- The weighted general linear model for longitudinal medical cost data – an application in colorectal cancer (Q5138533) (← links)
- Parametric Estimation of Quality Adjusted Lifetime (QAL) Distribution in Simple Illness-Death Model (Q5190585) (← links)
- Inferences about population means of health care costs (Q5424151) (← links)
- Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies (Q5424162) (← links)
- Using inverse-weighting in cost-effectiveness analysis with censored data (Q5424166) (← links)
- Estimating Incremental Cost‐Effectiveness Ratios and Their Confidence Intervals with Differentially Censored Data (Q5492100) (← links)
- Nonparametric Two‐Sample Tests of the Marginal Mark Distribution with Censored Marks (Q5738840) (← links)
- A Two-Part Framework for Estimating Individualized Treatment Rules From Semicontinuous Outcomes (Q5857108) (← links)
- Estimating the optimal individualized treatment rule from a cost‐effectiveness perspective (Q6079355) (← links)
- On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects (Q6160989) (← links)
- (Q6199221) (← links)
- Nonparametric Tests for Treatment Effect Heterogeneity With Duration Outcomes (Q6617801) (← links)
- deepAFT: a nonlinear accelerated failure time model with artificial neural network (Q6618381) (← links)
- Estimation and modeling of the restricted mean time lost in the presence of competing risks (Q6627760) (← links)
- Net-benefit regression with censored cost-effectiveness data from randomized or observational studies (Q6628515) (← links)